GUTS · Insider Trading
Fractyl Health, Inc. Common Stock
Every open-market purchase and sale reported by GUTS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | William Bradley | Director | Buy | +64,516 | +$39.90K |
| 2026-06-15 | Ajay Royan | Director | Buy | +23,000 | +$19.60K |
| 2026-06-11 | Ajay Royan | Director | A | +22,500 deriv. | — |
| 2026-06-11 | Christopher Charles Thompson | Director | A | +22,500 deriv. | — |
| 2026-06-11 | Clive Meanwell | Director | A | +22,500 deriv. | — |
| 2026-06-11 | William Bradley | Director | Buy | +68,493 | +$50.33K |
| 2026-06-11 | Samuel Conaway | Director | A | +22,500 deriv. | — |
| 2026-06-11 | Marc Elia | Director | A | +22,500 deriv. | — |
| 2026-06-11 | Kelly Ann Barnes | Director | A | +22,500 deriv. | — |
| 2026-06-11 | Ian Sheffield | Director | Buy | +35,000 | +$25.53K |
| 2026-06-11 | Harith Rajagopalan | Chief Executive Officer | Buy | +25,000 | +$18.25K |
| 2026-06-09 | Weber Lara Smith | Chief Financial Officer | Buy | +20,000 | +$13.71K |
| 2026-01-14 | Weber Lara Smith | Chief Financial Officer | A | +1,036,800 deriv. | — |
| 2025-12-17 | Harith Rajagopalan | Chief Executive Officer | A | +2,486,302 deriv. | — |
| 2025-12-17 | Sarah Toomey | General Counsel | A | +743,913 deriv. | — |
| 2025-12-17 | Jay David Caplan | President, Chief Product Off. | A | +845,226 deriv. | — |
| 2025-12-08 | Harith Rajagopalan | Chief Executive Officer | Buy | +10,416 | +$20.00K |
| 2025-09-04 | Ian Sheffield | Director | A | +45,000 deriv. | — |
| 2025-09-04 | Christopher Charles Thompson | Director | A | +45,000 deriv. | — |
| 2025-06-13 | Amy W Schulman | Director | A | +22,500 deriv. | — |
| 2025-06-13 | Clive Meanwell | Director | A | +22,500 deriv. | — |
| 2025-06-13 | Kelly Ann Barnes | Director | A | +22,500 deriv. | — |
| 2025-06-13 | Samuel Conaway | Director | A | +22,500 deriv. | — |
| 2025-06-13 | William Bradley | Director | A | +22,500 deriv. | — |
| 2025-06-13 | Marc Elia | Director | A | +22,500 deriv. | — |
| 2025-06-13 | Ajay Royan | Director | A | +22,500 deriv. | — |
| 2025-03-18 | Samuel Conaway | Director | — | — | — |
| 2025-03-18 | Kelly Ann Barnes | Director | Buy | +31,000 | +$40.21K |
| 2025-03-18 | Ajay Royan | Director | Buy | +17,901 | +$22.98K |
| 2025-03-17 | William Bradley | Director | Buy | +16,129 | +$20.36K |
| 2025-03-17 | Amy W Schulman | Director | Buy | +8,550 | +$9.96K |
| 2025-03-17 | Samuel Conaway | Director | Buy | +8,550 | +$9.96K |
| 2025-03-03 | Timothy Kieffer | Chief Scientific Officer | A | +204,980 deriv. | — |
| 2025-03-03 | Jay David Caplan | President, Chief Product Off. | A | +284,100 deriv. | — |
| 2025-03-03 | Sarah Toomey | General Counsel | A | +245,580 deriv. | — |
| 2025-03-03 | Harith Rajagopalan | Chief Executive Officer | A | +833,031 deriv. | — |
| 2025-03-03 | Lisa Davidson | Chief Financial Officer | A | +266,200 deriv. | — |
| 2025-02-03 | Jay David Caplan | President, Chief Product Off. | MIXED | — | −$7.78K |
| 2025-02-03 | Harith Rajagopalan | Chief Executive Officer | MIXED | — | −$15.74K |
| 2024-11-13 | Jay David Caplan | President, Chief Product Off. | MIXED | +123,060 | −$158.54K |
| 2024-11-13 | Harith Rajagopalan | Chief Executive Officer | MIXED | +120,407 | −$238.36K |
| 2024-09-13 | Jay David Caplan | President, Chief Product Off. | MIXED | +30,484 | −$26.15K |
| 2024-04-02 | Adrian Kimber | Chief Commercial Officer | A | +250,000 deriv. | — |
| 2024-02-08 | Corebridge DECO II, LLC | 10%+ Owner | C | +673,391 | — |
| 2024-02-08 | M28 Capital Management LP | Director | MIXED | +3,712,234 | +$14.00M |
| 2024-02-08 | Ajay Royan | Director | MIXED | +6,412,201 | +$5.00M |
| 2024-02-08 | Harith Rajagopalan | Chief Executive Officer | C | +9,318 | — |
| 2024-02-08 | Deerfield Mgmt III, L.P. | 10%+ Owner | C | +3,337,016 | — |
| 2024-02-08 | Clive Meanwell | Director | C | +277,890 | — |
| 2024-02-08 | GC Entrepreneurs Fund V, LP | 10%+ Owner | C | +19,201,240 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ajay Royan | Director | 433,433 | $407.47K |
| Harith Rajagopalan | Chief Executive Officer | 69,394 | $65.24K |
| Jay David Caplan | President, Chief Product Off. | 44,485 | $41.82K |
| Clive Meanwell | Director | 23,158 | $21.77K |
| William Bradley | Director | 12,428 | $11.68K |
| Ian Sheffield | Director | 2,917 | $2.74K |
| Kelly Ann Barnes | Director | 2,583 | $2.43K |
| Weber Lara Smith | Chief Financial Officer | 1,667 | $1.57K |
| Amy W Schulman | Director | 712 | $669 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the GUTS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.